National Cancer Institute
Scope
Date
~
-
Business & Politics
South Korea eyes new Arab boom via free trade deal with GCC nations
South Korea has struck a free trade agreement with the Gulf Cooperation Council (GCC), a group of six Arab nations, paving the way for Seoul to stre...
Dec 28, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Ocean carrier HMM's share price gains put KDB in hot seat
On Nov. 20, HMM Co., South Korea’s No. 1 ocean carrier, issued new 200 million shares after its two largest shareholders -- Korea Development ...
Dec 26, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio gets approval for cancer diagnostic device in Thailand
South Korean medical diagnostic company NGeneBio Co. announced on Friday that it has received approval for the sale of its in-vitro diagnostic medic...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Lunit acquires NZ-based AI diagnostics firm Volpara
South Korean medical AI company Lunit announced on Thursday that it will acquire New Zealand-based AI breast cancer diagnostics solutions company Vo...
Dec 14, 2023 (Gmt+09:00)
-
IPOs
LS Materials’ share price quadruples on Kosdaq debut
The share price of LS Materials Co., a South Korean energy storage device maker, quadrupled on its Kosdaq market debut Wednesday given its rosy earn...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s GC Cell targets global cell therapy CDMO business
GC Cell Corp., an affiliate of South Korea’s major pharmaceutical company GC Biopharma Corp., is targeting the cell therapy contract developme...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
-
North Korea
Kim Jong Un urges women to be good comrades — and give birth
SEOUL—Kim Jong Un has a new mission for North Korean women: Have more babies.Kim acknowledged the impoverished nation’s plunging bi...
Dec 07, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Ocean to develop submarine technology to evade detection
South Korea's Hanwha Ocean Co. has consecutively secured contracts for naval technology-related vessel research projects. The company recently annou...
Nov 29, 2023 (Gmt+09:00)
-
Bio & Pharma
Cytogen, Japan NCCH collaborate on cancer research
South Korea's Cytogen, Inc. announced on Monday it will start cancer research using circulating tumor cells (CTC) with the National Cancer Center Ho...
Nov 20, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
Nov 15, 2023 (Gmt+09:00)
-
Artificial intelligence
Lunit gets FDA approval for AI cancer diagnosis solution
South Korean medical AI company Lunit said on Tuesday its Lunit Insight DBT, an AI imaging diagnosis solution aiding in breast cancer diagnosis, has...
Nov 14, 2023 (Gmt+09:00)
-
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Nov 13, 2023 (Gmt+09:00)
-
Petrochemicals
Saudi Aramco’s $7 bn Korea project mired by labor shortage
Saudi Aramco’s $7 billion petrochemical project in South Korea, in what would be its largest-ever investment in the country, has hit a stumbli...
Nov 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Lunit participates in US gov't Cancer Moonshot
South Korea's medical AI company Lunit announced on Friday it will participate in the US President Joe Biden's cancer-conquering project Cancer Moon...
Nov 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Gencurix gets FDA OK for breast cancer prognosis analysis device
South Korean biotech company Gencurix Inc. announced on Wednesday its subsidiary GenoBio has received approval from the US Food and Drug Admini...
Nov 08, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
S.Korea tops global shipbuilding orders in October, surpassing China
South Korean shipbuilders won the most shipbuilding orders worldwide in October 2023. The country overtook China and claimed the lead in the global ...
Nov 07, 2023 (Gmt+09:00)
-
Artificial intelligence
SK Telecom invests in AI startups Allganize, Imprimed
SK Telecom Co. has invested a combined 9.4 billion won ($7.2 million) in artificial intelligence startups Allganize Inc. and Imprimed Inc., the top ...
Nov 06, 2023 (Gmt+09:00)
-
Research & Development
POSCO to build 2nd N.EX.T Hub research institute in Seongnam city
POSCO Group, which owns South Korea’s largest steelmaker, plans to build a second research institute near Seoul to support the conglomerate&rs...
Nov 02, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea to add India, Lithuania to list of nations eligible for E-9 visa
South Korea plans to allow non-professional workers from India and Lithuania to apply for the E-9 visa as the country struggles with a shrinking wor...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Motor, PIF to invest $500 mn to build car plant in Saudi Arabia
RIYADH – Hyundai Motor Co. has agreed with the Public Investment Fund, Saudi Arabia’s sovereign fund, to set up a joint venture to build...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Curocell to localize blood cancer drug by 2025
South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...
Oct 23, 2023 (Gmt+09:00)
-
Automobiles
Hyundai partners with University of London for African market strategy
Hyundai Motor Group announced on Friday its plan to establish two research centers in conjunction with the University of London (UoL) to delve int...
Oct 20, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB gets global rights to Chinese liver cancer drug
South Korea’s HLB Therapeutics Co. on Tuesday said its US subsidiary Elevar Therapeutics has acquired the global rights excluding South Kore...
Oct 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Noul releases AI-based diagnostic gizmo for cervical cancer
Noul Co., a South Korean company specializing in artificial intelligence (AI)-based blood and cancer diagnostic platforms, has entered the cancer di...
Oct 11, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio joins US gov't Cancer Moonshot project
South Korean medical diagnostic company NGeneBio Co. announced on Tuesday it joins US President Joe Biden's cancer-conquering project "Cancer Moonsh...
Oct 10, 2023 (Gmt+09:00)
-
Automobiles
SUVs, small pickups grab largest share of S.Korea's car market
Sport utility vehicles (SUV) and small pickup trucks in South Korea are occupying a larger share of the domestic automotive market.Industry sources ...
Oct 04, 2023 (Gmt+09:00)
-
Automobiles
Recreational cars grab largest share of S.Korea's automotive market
Recreational vehicles (RVs) in South Korea like sport utility vehicles (SUV) and small pickups are occupying a larger share of the domestic automoti...
Oct 04, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand